Clinical Trial Update: A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of a multi-agent regimen (clofarabine, etoposide, cyclophosphamide, peg-asparaginase, and vincristine) in children with ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Clolar (Clofarabine)
• Cytoxan (cyclophosphamide)
• Oncaspar (pegaspargase)
• Oncovin (vincristine)
• Toposar (Etoposide)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Status: COMPLETED